PT3082869T - Combinação de glicosaminoglicanos e ciclodextrinas - Google Patents

Combinação de glicosaminoglicanos e ciclodextrinas

Info

Publication number
PT3082869T
PT3082869T PT14830561T PT14830561T PT3082869T PT 3082869 T PT3082869 T PT 3082869T PT 14830561 T PT14830561 T PT 14830561T PT 14830561 T PT14830561 T PT 14830561T PT 3082869 T PT3082869 T PT 3082869T
Authority
PT
Portugal
Prior art keywords
glycosaminoglycans
cyclodextrins
combination
Prior art date
Application number
PT14830561T
Other languages
English (en)
Inventor
Pizzoni Angelo
Pizzoni Paolo
Original Assignee
Apharm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apharm Srl filed Critical Apharm Srl
Publication of PT3082869T publication Critical patent/PT3082869T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays or needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
PT14830561T 2013-12-18 2014-12-15 Combinação de glicosaminoglicanos e ciclodextrinas PT3082869T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002116A ITMI20132116A1 (it) 2013-12-18 2013-12-18 Associazione di glicosamminoglicani e ciclodestrine

Publications (1)

Publication Number Publication Date
PT3082869T true PT3082869T (pt) 2019-02-06

Family

ID=50115999

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14830561T PT3082869T (pt) 2013-12-18 2014-12-15 Combinação de glicosaminoglicanos e ciclodextrinas

Country Status (13)

Country Link
US (1) US9974803B2 (pt)
EP (1) EP3082869B1 (pt)
CN (1) CN105899233B (pt)
BR (1) BR112016013834B1 (pt)
CA (1) CA2932987C (pt)
EA (1) EA032372B1 (pt)
ES (1) ES2707971T3 (pt)
IT (1) ITMI20132116A1 (pt)
MA (1) MA39077A1 (pt)
PT (1) PT3082869T (pt)
TN (1) TN2016000206A1 (pt)
TR (1) TR201819270T4 (pt)
WO (1) WO2015092516A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153110A1 (it) * 2015-08-13 2017-02-13 Alfakjn S R L Composizione liquida iniettabile per uso nella terapia infiltrativa intra-articolare
IT201600075246A1 (it) 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
IT201800010415A1 (it) * 2018-11-19 2020-05-19 Innate S R L Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
EP4157290A4 (en) * 2020-06-02 2024-06-05 National University of Singapore COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREFOR

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282717B6 (sk) * 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
FR2811572B1 (fr) 2000-07-17 2003-04-18 Adir Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ES2493840T3 (es) * 2002-10-07 2014-09-12 Zymogenetics, Inc. Procedimiento de administración de FGF-18
US8455458B2 (en) * 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
CN1451369A (zh) * 2003-03-13 2003-10-29 吉林大学 环糊精衍生物在化妆品中的应用
EP1967186B1 (en) * 2005-12-27 2015-03-11 Lion Corporation Composition for soft contact lens and adsorption suppressing method
CN100594029C (zh) * 2006-07-24 2010-03-17 凌沛学 一种关节腔内注射用药物组合物
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
CN101259139A (zh) * 2008-03-13 2008-09-10 北京阜康仁生物制药科技有限公司 一种用于消炎镇痛的药用组合物
US8466278B2 (en) * 2008-09-22 2013-06-18 Arcarios B.V. Carboxyethylated cyclodextrin polysulfates useful as medicaments
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
CH705713B1 (de) * 2012-09-21 2013-05-15 Labo Cosprophar Ag Dermokosmetische Zusammensetzung zur topischen Anwendung.
CN103301118A (zh) * 2013-06-27 2013-09-18 海南卫康制药(潜山)有限公司 注射用精氨酸布洛芬组合物

Also Published As

Publication number Publication date
MA39077A1 (fr) 2017-11-30
TN2016000206A1 (en) 2017-10-06
EP3082869A1 (en) 2016-10-26
TR201819270T4 (tr) 2019-01-21
CN105899233B (zh) 2020-01-17
BR112016013834B1 (pt) 2022-11-22
CA2932987C (en) 2021-10-12
US20170035799A1 (en) 2017-02-09
US9974803B2 (en) 2018-05-22
EA032372B1 (ru) 2019-05-31
EP3082869B1 (en) 2018-10-31
ES2707971T3 (es) 2019-04-08
BR112016013834A2 (pt) 2017-08-08
EA201691246A1 (ru) 2016-10-31
CA2932987A1 (en) 2015-06-25
WO2015092516A1 (en) 2015-06-25
ITMI20132116A1 (it) 2015-06-19
CN105899233A (zh) 2016-08-24

Similar Documents

Publication Publication Date Title
HUS2500021I1 (hu) Ariléterek és azok felhasználásai
IL273205A (en) Preparations and methods
GB2533892B (en) Compositions and methods
PL2968100T3 (pl) Kombinacje amidotiazoli alkilowych i konserwantów
ZA201601524B (en) Production of graphene and graphane
GB201308072D0 (en) Compositions and methods
PL2971019T3 (pl) Namnażanie organizmu i związane sposoby i kompozycje
GB201305277D0 (en) Novel combination and use
EP3017225A4 (en) Bracket and use
IL244214B (en) Thienopiperidine derivative and its use
PT2978326T (pt) Cigarros e a sua construção
GB201305813D0 (en) Compositions and methods
GB2586104B (en) Cyclodextrin
SG11201507389RA (en) Integration of hydro-dechlorination and hydro-regeneration
ZA201601880B (en) Hetero-transglycosylase and uses thereof
PT3082869T (pt) Combinação de glicosaminoglicanos e ciclodextrinas
EP2968274A4 (en) MEROPENE DERIVATIVES AND USES THEREOF
HUE050547T2 (hu) Oligoszaccharid konjugátumok és alkalmazási eljárások
TWI559919B (en) The uses of hydroxyl polymethoxylflavones and/or derivative thereof
TWM475821U (en) Structure of mosquito-catch
EP3003323A4 (en) POLYSACCARIDE COMPOSITIONS AND CORRESPONDING METHODS
GB201301393D0 (en) Kiddibidet and pottibidet
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods
GB201304166D0 (en) CelebQuiff and Instant Quiff